Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Merck's (MRK) Keytruda sBLA Accepted by FDA for Gastric Cancer
03:12pm, Friday, 14'th Apr 2023
Merck's (MRK) application seeking approval for Keytruda in combination with fluoropyrimidine- and platinum-containing chemotherapy for the early treatment of locally advanced, unresectable or metastat
Markets Rally on Cooler Economic Data; More Results on Deck
07:44pm, Thursday, 13'th Apr 2023
Weaker economic prints are beginning to reveal an alternative narrative: perhaps the Fed has done enough already.
Citi upgrades Merck to buy
02:26pm, Thursday, 13'th Apr 2023
The "Halftime Report" traders debate the biggest analyst calls of the day
Why Is Merck (MRK) Stock Up Today?
10:09am, Thursday, 13'th Apr 2023
Merck (NYSE: MRK ) stock is on the move Thursday after the pharmaceutical company got an update from the FDA concerning Keytruda. Keytruda is Merck's anti-PD-1 therapy.
Blue-Chip Pharma Stock Jumps on Bull Note, FDA Approval
09:18am, Thursday, 13'th Apr 2023
Citigroup upgraded blue-chip pharma giant Merck & Co., Inc. (NYSE:MRK) to "buy" and hiked its price target to $130, citing "materially revised forecasts" for the company's experimental cancer treatme
Merck's stock leads the Dow's early gainers after Citi turns bullish, raises price target by 24%
06:20am, Thursday, 13'th Apr 2023
Shares of Merck & Co. Inc. MRK rose 1.1% to pace the Dow Jones Industrial Average's DJIA premarket gainers, after Citi Research turned bullish on the drug maker, citing “materially revised forecasts
Merck shares fall after US FDA halts new patient enrollment of MS drug candidate trials
09:38am, Wednesday, 12'th Apr 2023
The US Food and Drug Administration has hit pause on patient enrollment for German drugmaker Merck's multiple sclerosis drug candidate evobrutinib after initial lab results indicated liver injury duri
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
Diving Into the Smead Value Fund's Top Holdings as Value Conference Approaches
04:29pm, Monday, 10'th Apr 2023
With the goal of generating long-term capital appreciation, the Smead Value Fund (Trades, Portfolio) is known for investing in a concentrated number of stocks that have strong competitive advantages.
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
10:41am, Monday, 10'th Apr 2023
Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
My 30-30 Club Gets More Exclusive: Microsoft, Merck and 36 More
10:30am, Monday, 10'th Apr 2023
What do Mike Trout and Microsoft ( MSFT , Financial) have in common?
Merck (MRK) Keytruda Studies in Difficult-to-Treat Cancers Fail
09:54am, Monday, 10'th Apr 2023
Merck (MRK) and Eisai announce the discontinuation of the phase III LEAP-003 study seeking approval of the Keytruda and Lenvima combo. Another phase III LEAP-017 study fails to meet goals.
April MDA Breakout Stocks/ETFs Week 15 - 2023: High-Frequency Gainers To Give You An Edge
06:05am, Sunday, 09'th Apr 2023
Two new Breakout Stocks for Week 15 with better than 10% short-term upside, ETF updates and a Dow 30 Picks. Average cumulative returns for 2023 are +48.5% YTD. Last week peak stock gains were in ATEX
5 Relatively Safe And Cheap Dividend Stocks To Invest In - April 2023
09:30am, Saturday, 08'th Apr 2023
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying, and are offering large discounts to their historical norms. We go ove
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
01:14pm, Friday, 07'th Apr 2023
Medical stocks are holding up amid economic and market uncertainty. The post 5 S&P 500 Stocks Showing Strength As Recession Fears Rise appeared first on Investor's Business Daily.
